Tevogen Bio to list in US through $1.2B SPAC deal - Breaking The News
Download our appPlay StoreApp Store

Tevogen Bio to list in US through $1.2B SPAC deal

EPA-EFE/JUSTIN LANE

Tevogen Bio, a clinical-stage biotech company, announced on Thursday it plans to go public via a merger with special purpose acquisition company (SPAC) Semper Paratus Acquisition.

The merger, valued at about $1.2 billion, is expected to conclude in the fourth quarter of this year, at which point the merged company will be known as Tevogen Bio Holdings. Shares of the new entity will be listed in New York under the ticker symbol "TVGN."

SPACs, also known as "blank check companies," are shell corporations that are listed on a stock exchange with the explicit purpose of acquiring a private company. This process enables the private company to become publicly listed, bypassing the traditional IPO process and its extensive regulations.

Related Stocks
ETH/USD
BTC/USD
Related News
Japan allegedly to make crypto assets financial products
The Japanese Financial Services Agency (FSA) is planning to give cryptocurrency assets the status of financial products, the Nikkei reported on Sunday. The FSA will submit a bill to amend Japan's Financial Instruments and Exchange Act as early as 2026, according to the report, which did not cite its sources.In addition, the FSA allegedly plans to adopt regulations prohibiting the buying and selling of cryptocurrencies based on undisclosed internal information. The...
Trump allegedly pardons BitMex co-founders
United States President Donald Trump granted pardons to the three co-founders of cryptocurrency trading platform BitMEX, CNBC reported on Friday.According to the report, the US president issued the pardons on Thursday for the three BitMEX co-founders, Arthur Hayes, Benjamin Delo, and Samuel Reed, who were indicted in 2022 for violations of the Bank Secrecy Act after they were accused of not implementing anti-money laundering measures. The...
Bitcoin drops below $84K, down 3.7% after inflation gauge
Major cryptocurrencies experienced declines on Friday, with Bitcoin sliding under $84,000, as market participants reacted to an unexpectedly strong inflation gauge reading alongside concerns over the recent trade measures announced by US President Donald Trump.The core Personal Consumption Expenditures Price Index (PCE) increased by 0.4% during February, recording its biggest monthly gain in more than a year, according to U.S. Commerce Department...
Fed's Kashkari: No use case for cryptocurrency
Federal Reserve Bank of Minneapolis President Neel Kashkari said on Wednesday that he is a "pretty big skeptic" on cryptocurrency, arguing that "nobody has found a legitimate use case" for it, apart from as an instrument of speculation and to circumvent bank regulations. Kashkari repeated that the Fed has made good progress on inflation but that there is "more work to do" to bring it down to the 2% target. He praised the resilience of the labor market in light...

Please observe our Terms of Use. The price information is time delayed to varying extents, but as a rule by 15 minutes or more, according to the regulations of the selected stock exchange and/or licensors and the type of securities.

© 2025 TeleTrader Software GmbH. All rights reserved

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.